Trandolapril. How does it differ from other angiotensin converting enzyme inhibitors?

Area of Science:

• Pharmacology and Therapeutics
• Cardiovascular Medicine

Background:

• Trandolapril is an angiotensin converting enzyme (ACE) inhibitor with unique properties contributing to its long duration of action.
• Key differentiating factors include its long elimination half-life, high lipophilicity, potent ACE inhibition, and strong affinity for the ACE enzyme, resulting in a prolonged biological half-life.

Purpose of the Study:

• To evaluate the duration of blood pressure lowering effects of trandolapril compared to other commercially available ACE inhibitors.
• To assess the clinical relevance of trandolapril's pharmacokinetic and pharmacodynamic properties, particularly its long-acting nature.

Main Methods:

• Literature analysis of 19 published studies utilizing ambulatory blood pressure monitoring in patients with mild to moderate hypertension.
• Reconstruction of blood pressure changes over time and calculation of mean trough: peak ratios for once-daily administered ACE inhibitors.
• Comparison of trandolapril's trough: peak ratios with those of enalapril and lisinopril.

Main Results:

• Trandolapril demonstrated near-total ACE inhibition 24 hours after a single dose and significant inhibition 72 hours after drug withdrawal following long-term therapy.
• Once-daily administration of trandolapril resulted in trough: peak ratios of 50% to 100%, exceeding the 50% threshold for sustained blood pressure control.
• Literature analysis indicated that trandolapril provides a blood pressure-lowering effect for the entire 24-hour dosing period, with potential for extended duration.

Conclusions:

• Trandolapril exhibits a long duration of action, characterized by sustained blood pressure lowering for a full 24-hour period.
• Its pharmacokinetic and pharmacodynamic profile supports once-daily dosing and offers a clinically relevant advantage over other ACE inhibitors with shorter durations of action.
• Occasional missed doses of trandolapril may still result in a blood pressure-lowering effect extending beyond 24 hours.